AAAAAA

   
Results: 1-7 |
Results: 7
CHANGES IN USE OF ANTIRETROVIRAL THERAPY IN REGIONS OF EUROPE OVER TIME
Authors: KIRK O MOCROFT A KATZENSTEIN TL LAZZARIN A ANTUNES F FRANCIOLI P BRETTLE RP PARKIN JM GONZALESLAHOZ J LUNDGREN JD
Citation: O. Kirk et al., CHANGES IN USE OF ANTIRETROVIRAL THERAPY IN REGIONS OF EUROPE OVER TIME, AIDS, 12(15), 1998, pp. 2031-2039
THE RELATIVE PROGNOSTIC VALUE OF PLASMA HIV RNA LEVELS AND CD4 LYMPHOCYTE COUNTS IN ADVANCED HIV-INFECTION
Authors: LEPRI AC KATZENSTEIN TL ULLUM H PHILLIPS AN SKINHOJ P GERSTOFT J PEDERSEN BK
Citation: Ac. Lepri et al., THE RELATIVE PROGNOSTIC VALUE OF PLASMA HIV RNA LEVELS AND CD4 LYMPHOCYTE COUNTS IN ADVANCED HIV-INFECTION, AIDS, 12(13), 1998, pp. 1639-1643
HIV-INFECTED INDIVIDUALS WITH THE CCR5-DELTA-32 CCR5 GENOTYPE HAVE LOWER HIV RNA LEVELS AND HIGHER CD4 CELL COUNTS IN THE EARLY YEARS OF THE INFECTION THAN DO PATIENTS WITH THE WILD-TYPE/
Authors: KATZENSTEIN TL EUGENOLSEN J HOFMANN B BENFIELD T PEDERSEN C IVERSEN AKN SORENSEN AM GARRED P KOPPELHUS U SVEJGAARD A GERSTOFT J
Citation: Tl. Katzenstein et al., HIV-INFECTED INDIVIDUALS WITH THE CCR5-DELTA-32 CCR5 GENOTYPE HAVE LOWER HIV RNA LEVELS AND HIGHER CD4 CELL COUNTS IN THE EARLY YEARS OF THE INFECTION THAN DO PATIENTS WITH THE WILD-TYPE/, Journal of acquired immune deficiency syndromes and human retrovirology, 16(1), 1997, pp. 10-14
PNEUMOCOCCAL VACCINATION OF HIV-INFECTED INDIVIDUALS - SAFETY AND EFFICACY
Authors: KATZENSTEIN TL
Citation: Tl. Katzenstein, PNEUMOCOCCAL VACCINATION OF HIV-INFECTED INDIVIDUALS - SAFETY AND EFFICACY, AIDS patient care, 11(4), 1997, pp. 269-275
DECREASED SHORT-TERM PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE SUBJECTS
Authors: ULLUM H VICTOR J KATZENSTEIN TL GERSTOFT J GOTZSCHE PC BENDTZEN K SKINHOJ P PEDERSEN BK
Citation: H. Ullum et al., DECREASED SHORT-TERM PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE SUBJECTS, The Journal of infectious diseases, 175(6), 1997, pp. 1507-1510
LONGITUDINAL SERUM HIV RNA QUANTIFICATION - CORRELATION TO VIRAL PHENOTYPE AT SEROCONVERSION AND CLINICAL OUTCOME
Authors: KATZENSTEIN TL PEDERSEN C NIELSEN C LUNDGREN JD JAKOBSEN PH GERSTOFT J
Citation: Tl. Katzenstein et al., LONGITUDINAL SERUM HIV RNA QUANTIFICATION - CORRELATION TO VIRAL PHENOTYPE AT SEROCONVERSION AND CLINICAL OUTCOME, AIDS, 10(2), 1996, pp. 167-173
ASSESSMENTS OF PLASMA HIV RNA AND CD4 CELL COUNTS AFTER COMBINED PNEUMOVAX(R) AND TETANUS TOXOID VACCINATION - NO DETECTABLE INCREASE IN HIV REPLICATION 6 WEEKS AFTER IMMUNIZATION
Authors: KATZENSTEIN TL GERSTOFT J NIELSEN H
Citation: Tl. Katzenstein et al., ASSESSMENTS OF PLASMA HIV RNA AND CD4 CELL COUNTS AFTER COMBINED PNEUMOVAX(R) AND TETANUS TOXOID VACCINATION - NO DETECTABLE INCREASE IN HIV REPLICATION 6 WEEKS AFTER IMMUNIZATION, Scandinavian journal of infectious diseases, 28(3), 1996, pp. 239-241
Risultati: 1-7 |